Gland Pharma bags USFDA nod for breast cancer treatment injection Eribulin Mesylate
Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for Eribulin Mesylate Injection, 0.5 mg/mL Single Dose Vial (Product). Eribulin Mesylate Injection is used for the treatment of breast cancer that has spread to other parts of the body. “The Product is expected to […]